J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M500542-JLR200 on January 26, 2006

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M500542-JLR200v1
47/4/844    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nichols, F. C.
Right arrow Articles by Smith, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nichols, F. C.
Right arrow Articles by Smith, M. B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 47, 844-853, April 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology

Structures and biological activities of novel phosphatidylethanolamine lipids of Porphyromonas gingivalis

Frank C. Nichols*,1, Birgit Riep*,{dagger}, Jiyoung Mun§, Martha D. Morton§, Toshihisa Kawai**, Floyd E. Dewhirst** and Michael B. Smith§

* Department of Periodontology, University of Connecticut School of Dental Medicine, Farmington, CT 06030
{dagger} Department of Periodontology and Synoptic Dentistry, Charité-University Medicine Berlin, 13353 Berlin, Germany
§ Department of Chemistry, U3060, University of Connecticut, Storrs, CT 06269
** Department of Molecular Genetics, The Forsyth Institute, Boston, MA 02115

Published, JLR Papers in Press, January 26, 2006.

1 To whom correspondence should be addressed. e-mail: nichols{at}nso.uchc.edu


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The Gram-negative periodontal pathogen Porphyromonas gingivalis synthesizes several classes of novel phosphorylated complex lipids, including the recently characterized phosphorylated dihydroceramides. These sphingolipids promote the interleukin-1 (IL-1)-mediated secretion of inflammatory mediators from fibroblasts, including prostaglandin E2 and 6-keto prostaglandin F2{alpha}, and alter gingival fibroblast morphology in culture. This report demonstrates that one additional class of phosphorylated complex lipids of P. gingivalis promotes IL-1-mediated secretory responses and morphological changes in cultured fibroblasts. Structural characterization identified the new phospholipid class as 1,2-diacyl phosphatidylethanolamine, which substituted predominantly with isobranched C15:0 and C13:0 fatty acids. The isobranched fatty acids, rather than unbranched fatty acids, and the phosphoethanolamine head group were identified as the essential structural elements required for the promotion of IL-1-mediated secretory responses. These structural components are also observed in specific phosphorylated sphingolipids of P. gingivalis and likely contribute to the biological activity of these substances, in addition to the phosphatidylethanolamine lipids described in this report.

Supplementary key words interleukin-1ß • prostaglandin E2 • gingival fibroblast • long-chain base • gas chromatography-mass spectrometry • electrospray tandem mass spectrometry


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Porphyromonas gingivalis is a Gram-negative anaerobic organism that resides in the gingival sulcus surrounding the teeth, particularly at sites of chronic inflammatory or destructive periodontal diseases. A recent report demonstrated that P. gingivalis synthesizes two major phosphorylated dihydroceramides, one of which potentiates interleukin-1 (IL-1)-mediated prostaglandin E2 (PGE2) secretory responses in gingival fibroblasts and markedly alters gingival fibroblast morphology in culture (1). These lipids are also recovered from diseased tooth roots (2), and indirect evidence indicates that the phosphoglycerol dihydroceramide lipids are the primary ceramides of P. gingivalis recovered in gingival tissues at disease sites (3). Therefore, P. gingivalis produces biologically active complex lipids that are recovered at periodontal disease sites.

Recent investigations have demonstrated that P. gingivalis produces one additional class of phospholipids that also demonstrate substantial capacity to promote IL-1ß-mediated prostaglandin secretion from gingival fibroblasts. However, this lipid class is not a sphingolipid, because it lacks amide-linked fatty acid. This report describes the structural characterization of this new phospholipid class and demonstrates the capacity of this lipid to promote prostaglandin secretory responses and morphological changes in cultured gingival fibroblasts. Lastly, using a structural analog as a control for the bacterial lipid fraction as well as the hydrolysis products of this bacterial lipid class, this report defines the critical structural components of the phosphorylated lipids of P. gingivalis that appear to account for their biological activity.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
P. gingivalis (ATCC 33277, type strain) was grown in batch suspension culture after verification of anaerobic growth of Gram-negative rods in thioglycollate medium and demonstration of black-pigmented bacterial colonies on blood agar plates only with anaerobic culture conditions. P. gingivalis was grown under anaerobic conditions in basal (peptone, trypticase, and yeast extract) medium supplemented with hemin and menadione (Sigma-Aldrich, St. Louis, MO) and brain heart infusion as described previously (1). The suspension cultures were incubated in an anaerobic chamber flushed with N2 (80%), CO2 (10%), and H2 (10%) at 37°C for 5 days, and the bacteria were harvested by centrifugation (3,000 g for 20 min). A sample of P. gingivalis pellet was extracted using a modification of the phospholipid extraction procedure of Bligh and Dyer (4) and Garbus et al. (5). P. gingivalis lipid extract was fractionated by HPLC using a semipreparative HPLC column (1 x 25 cm silica gel, 5 µm; Supelco, Inc., Bellefonte, PA) and eluted isocratically with hexane-isopropanol-water (6:8:0.75, v/v/v; solvent A) (6). Replicate fractionations were pooled by fraction number, and lipid recovery was determined for each fraction as described previously (1). GC-MS and electrospray-MS analysis (see below) demonstrated that the phosphatidylethanolamine lipids were recovered in greatest abundance and highest purity in HPLC fractions 23 and 24.

Lipid film preparation
Phosphatidylethanolamine lipids were dissolved in ethanol to achieve a final concentration of 0.5 µg/µl, and 20 µl of each lipid fraction was deposited in 35 mm plastic culture wells, as described previously (1). The ethanol was evaporated overnight, leaving a lipid residue covering most of the culture well surface. Vehicle control wells received only ethanol solvent. Primary cultures of gingival fibroblasts were obtained by explant culture using gingival tissue samples recovered from healthy sites during periodontal surgical procedures, as described previously (7). Gingival tissue samples were obtained according to a protocol approved by the Institutional Review Board, and participants provided written informed consent. Gingival fibroblasts were inoculated into culture wells to achieve a cell number/surface area equivalent to confluent cultures. After 2 h of exposure to bacterial lipids, the culture medium was supplemented with either control medium or medium containing recombinant human IL-1ß or IL-1{alpha} (final concentration, 10 ng/ml; Immunex, Seattle, WA). The cultures were then incubated for an additional 24 h, after which the culture medium was recovered and frozen.

Quantification of prostaglandins in culture medium samples
PGF2{alpha}, 6-keto PGF1{alpha}, and PGE2 were quantified in medium samples using a modification of the method of Luderer, Riley, and Demers (8), as described previously (1, 9). Each medium sample was supplemented with 100 ng of D4-PGF2{alpha}, D4-6-keto PGF1{alpha}, and D4-PGE2 and the pH adjusted to pH 3.5 with concentrated formic acid. The acidified medium samples were then applied to reverse-phase preparative columns (Supelclean, LC-18 SPE tubes, 6 ml; Supelco, Inc.) mounted on a vacuum manifold, the columns were washed, and enriched prostaglandins were eluted with 100% methanol (1). The eluted prostaglandins were then supplemented with 2 ml of 1% formic acid in water, and the prostaglandins were extracted twice with 2 ml of chloroform. The chloroform extracts were dried under nitrogen.

All derivatizing agents were obtained from Pierce Chemical Corp. (Rockford, IL). Prostaglandin samples were derivatized using the method of Waddell, Blair, and Wellby (10). Prostaglandin samples were first treated with 2% methoxylamine hydrochloride in pyridine (30 µl). After standing overnight at room temperature, the samples were dried under nitrogen, dissolved in acetonitrile (30 µl), and treated with pentafluorobenzyl bromide (35%, v/v, in acetonitrile; 10 µl) and diisopropylethylamine (10 µl). The samples were vortexed, incubated for 20 min at 40°C, and evaporated under nitrogen. The residue was then treated with bistrimethylsilyl-trifluoroacetamide (50 µl) and allowed to stand at room temperature for 4–5 days.

Synthesis of isobranched C15:0 (13-methyl tetradecanoic acid)
A suspension of Mg turnings (1.21 g, 49.8 mmol) in tetrahydrofuran (10 ml) was treated with 1-bromo-3-methylbutane (5 ml, 41.5 mmol) with vigorous stirring at room temperature. After initiation of the reaction, tetrahydrofuran (25 ml) was added and stirred until the reaction mixture reached ambient temperature. A solution of 10-bromo-1-decanol (3 g, 12.6 mmol) in tetrahydrofuran (27 ml) was cooled to –78°C and treated with the Grignard reagent described above together with Li2CuCl4 (0.1 M, 4 ml) at –78°C. The reaction mixture was stirred overnight, during which time the temperature increased to room temperature, giving a dark solution. After stirring for 5 min with saturated aqueous NH4Cl (15 ml), water (150 ml) and ethyl acetate (150 ml) were added. The organic layer was separated and washed with saturated aqueous NaHCO3 and brine, dried with MgSO4, and concentrated in vacuo. Purification with silica column chromatography gave 13-methyl-1-tetradecanol as a colorless oil (2.74 g, 12.0 mmol, 95%). The 13-methyl-1-tetradecanol was added to a 50 ml flask containing chromium trioxide in aqueous sulfuric acid (Jones' reagent) and allowed to stir at ambient temperature for 2 h. The solution was extracted with 3 x 50 ml of dichloromethane, the organic fractions were dried (MgSO4) and filtered, and the solvent was removed in vacuo to give 2.79 g (11.5 mmol, 96%) of 13-methyltetradecanoic acid. The free fatty acid was treated with thionyl chloride to form the acid chloride, followed by treatment with methanol to form the methyl ester. The fatty acid methyl ester was evaluated by GC-MS as described below.

Hydrolysis of P. gingivalis phosphatidylethanolamine lipids
Analysis of esterified fatty acids was accomplished by treating a sample of the phosphatidylethanolamine lipid fraction with 0.5 N NaOCH3 in anhydrous methanol (0.5 ml, 40°C for 20 min). The reaction was stopped with the addition of 100 µl of glacial acetic acid and 1 ml of water. The sample was then extracted twice with hexane, and the contents were dried under nitrogen. The sample was reconstituted in hexane for GC-MS analysis.

Approximately 1 mg of P. gingivalis phosphatidylethanolamine lipid was dissolved in anhydrous ether (1 ml) and combined with 1% calcium chloride (1.3 ml) and 2 units of phospholipase C (Clostridium perfringens; 4.6 U/mg; Sigma-Aldrich) in Tris buffer (17.5 mM, 4 ml, pH 7.3) (11). The mixture was incubated for 2 h at 30°C with frequent vortexing, and the reaction was stopped by adding 0.1 M HCl (0.2 ml). The hydrolysis products were extracted and treated with bistrimethylsilyl-trifluoroacetamide (Pierce Chemical Corp.; 40 µl, overnight).

GC-MS analysis
GC-MS was carried out on a Hewlett-Packard 5890 gas chromatograph interfaced with a 5988A mass spectrometer. Prostaglandin samples were applied to an SPB-1 column (12 m x 0.2 mm, 0.33 µm film thickness; Supelco, Inc.) held at 100°C. Prostanoid samples were analyzed using a temperature program of 2°C/min from 100°C to 240°C. The injector block was held at 260°C, and the transfer tube was maintained at 280°C. Prostaglandin derivatives were detected using electron capture-negative chemical ionization, as described previously (1). Prostaglandin levels were quantified using selected ion monitoring of the characteristic base peak ions of the deuterated and authentic prostaglandins.

Fatty acid methyl esters recovered from P. gingivalis phosphatidylethanolamine lipids were analyzed using electron-impact GC-MS. The sample was applied to an SPB-1 column (12 m x 0.2 mm, 0.33 µm film thickness; Supelco, Inc.) held at 100°C, and the column was heated at 10°C/min to 270°C. The injector block was held at 260°C, and the transfer tube was maintained at 280°C. The ion source temperature was 150°C, the electron energy was 70 eV, and the emission current was ~300 mA. The mass spectrometer was used in the electron-impact mode with ion acquisition of 50 to 700 amu. The retention time and mass spectrum of synthetic isobranched (iso)C15:0 methyl ester were used to verify the identity of the dominant C15:0 methyl ester fatty acid recovered from P. gingivalis phosphatidylethanolamine lipids. Straight-chain fatty acid standards were also used to verify the identity of the remaining fatty acid methyl esters recovered from phosphatidylethanolamine lipids.

For diglyceride analyses, the trimethylsilyl lipid derivatives were analyzed by GC-MS using a SPB-1 column (15 m x 0.25 mm x 0.1 mm film; Supelco, Inc.) and a temperature program of 200°C to 290°C at 10°C/min using the mass spectrometer in the electron-impact mode.

Electrospray-tandem mass spectrometry analysis of dihydroceramide lipids
Electrospray-MS analysis was accomplished using a Micromass Quattro II mass spectrometer system. The P. gingivalis phosphatidylethanolamine lipid fraction as well as all HPLC lipid fractions were dissolved in hexane-isopropanol (6:8, v/v; elution solvent) and injected at a maximum concentration of 100 µg/ml. Lipid samples (10 µl) were infused at a flow rate of 20 µl/min. For electrospray positive ion analyses, the desolvation and inlet block temperatures were 100°C and 150°C, respectively, and the transcapillary potential was 3,500 V. For electrospray negative ion analyses, the desolvation and inlet block temperatures were 80°C and 100°C, respectively, and the transcapillary potential was 3,000 V. The cone voltage was usually 30 V, and the mass acquisition range was 0–2,000 amu for initial electrospray MS analyses. Tandem mass spectrometry (MS/MS) analysis used a collision energy of between 28 and 30 V, and argon was introduced at a pressure of 10–2 to 10–4 torr. The gas and collision energies were adjusted to minimize parent ion recoveries and maximize daughter ion recoveries. These conditions were used for both positive and negative ion electrospray-MS/MS analyses.

NMR analyses
NMR data were collected on a Bruker DRX-400, a Bruker Avance 500, and a Varian INOVA 600 (operating frequencies of 400.144, 500.13, and 599.75 megahertz, respectively). One-dimensional 1H, 13C, and 31P, as well as two-dimensional 1H-1H Correlated Spectroscopy (COSY), 1H-13C Heteronuclear Multiple Quantum Correlation (g-HMQC), 1H-C-C-13C Heteronuclear Multiple Bond Correlation Spectroscopy (g-HMBC), Total Correlated Spectroscopy (TOCSY), Nuclear Overhauser Spectoscopy (NOESY), and 1H-31P (gHMBC), were acquired for P. gingivalis phosphatidylethanolamine lipids dissolved in deuterated solvents of specified composition (CDCl3 or CD3OD). These data allowed the assignment of proton and carbon resonances of the dihydroceramide base and the phosphate side chain of the molecule, as well as specific components of the aliphatic chains.

Data analysis
Statistical tests included one-factor ANOVA comparing prostaglandin secretion between culture treatment groups and the Fisher PLSD or Scheffe F-test for significant differences between treatment categories.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
The phosphatidylethanolamine class was isolated as a highly enriched sample using semipreparative HPLC. The phosphatidylethanolamine lipids of P. gingivalis were recovered in highest concentration in HPLC fractions 23 and 24 (~15 mg recovered), as determined by GC-MS and electrospray-MS analysis of HPLC fractions. Positive ion electrospray-mass spectra and tandem mass spectra of phosphatidylethanolamine lipids are shown in Fig. 1 . Phosphatidylethanolamine lipids isolated by HPLC were analyzed without derivatization, and the resulting ion products shown in Fig. 1A suggest that this lipid class consists of either two or four major products. However, positive ion electrospray-MS/MS demonstrated that the m/z 664 and 636 parent ions produce the m/z 523 and 495 daughter ions, respectively (Fig. 1B, C). Therefore, the number of major lipid products shown in Fig. 1A is limited to two major lipid products of 663 and 635 amu (positive ions are generated through the formation of proton adducts, resulting in ion masses of m/z 664 and 636). Additional evidence provided below confirms the proposed lipid structures shown in Fig. 1.


Figure 1
View larger version (20K):
[in this window]
[in a new window]
  		Fig. 1. Positive ion electrospray-MS and electrospray-tandem mass spectrometry (MS/MS) analysis of phosphatidylethanolamine lipids of P. gingivalis. Lipids were separated by semipreparative HPLC, as described previously (1). GC-MS and electrospray-MS analyses demonstrated that the phosphatidylethanolamine lipids of interest were recovered in greatest abundance and highest purity in HPLC fractions 23 and 24. A sample of phosphatidylethanolamine lipids was subjected to positive ion electrospray analysis (A) and electrospray-MS/MS analysis (B, C). A: Positive ion mass spectrum of phosphatidylethanolamine lipids and the proposed structures of the major components. B, C: Daughter positive ions produced from the major high-mass ions, m/z 636 and 664, respectively. Proton/carbon NMR assignments are listed in the table at bottom, and the corresponding assignments are listed on the chemical structure shown in A. MeOH, methanol.

 
By NMR (see table at the bottom of Fig. 1), the proton resonance at H-4 (5.21 ppm) showed TOCSY and COSY correlations to protons at 3.94 ppm (H-3, 2H), 4.37, and 4.18 ppm (H-5 protons) (proton and carbon assignments are listed on the chemical structure shown in Fig. 1A). Proton resonances on H-3, H-2, and H-1 were broadened by 31P coupling at 3.94, 4.09, and 3.17 ppm, respectively. The 4.09 ppm protons represent the -CH2-OP protons of the phosphoethanolamine head group. The 3.17 ppm proton signal represents -CH2-N of the ethanolamine moiety. Because proton signals of the glycerol chain are asymmetric and the most upfield signal is coupled to 31P, this evidence confirms the position of the phosphoethanolamine head group at the terminal end of the glycerol. The COSY also indicated that the fatty acid aliphatic chains are not hydroxy substituted, as was observed with other dominant complex lipid classes of P. gingivalis (1), but are branched at the distal end. The 1H-13C HMBC analysis revealed that the four protons at 2.30 ppm correlate with the inequivalent carbonyl carbons at 173.4 and 173.0 ppm. Therefore, the phosphatidylethanolamine lipids of P. gingivalis exist as 1,2-diacyl glycerol 3-phosphoethanolamine lipids substituted predominantly with isobranched fatty acids. The chirality of carbon 2 of the glycerol chain remains to be characterized, although hydrolysis with cobra venom factor completely destroyed phosphatidylethanolamine lipids of P. gingivalis. If the carbon 2 chirality were of the unnatural type (D-glycerophosphatides), cobra venom factor would not destroy this lipid class (12).

Negative ion electrospray-MS of P. gingivalis phosphatidylethanolamine lipids demonstrated two dominant lipid ions of m/z 662 and 634 (data not shown). Electrospray-MS/MS analysis revealed daughter negative ions of m/z 241, 196, and 140 produced from the m/z 662 parent ion (Fig. 2 , bottom). The m/z 241 ion is consistent with the negative ion of C15:0, and the m/z 140 ion is consistent with a protonated phosphoethanolamine moiety (1). The m/z 195 ion likely results from the loss of both fatty acids, with oxygen retention on the phosphoethanolamine-glycerol moiety. In turn, the m/z 634 parent ion (Fig. 2, top) produces daughter ions of m/z 140 and 196 as well. However, the m/z 634 parent ion produces daughter negative ions of m/z 213 and 241, suggesting the presence of both C13:0 and C15:0, respectively. Therefore, both parent ions contain similar phosphorylated head groups but differ with regard to fatty acid substitutions.


Figure 2
View larger version (13K):
[in this window]
[in a new window]
  		Fig. 2. Negative ion electrospray-MS/MS analysis of phosphatidylethanolamine lipids of P. gingivalis. The lipid sample described for Fig. 1 was shown to contain two dominant negative ions (m/z 662 and 634). The m/z 662 parent negative ion produced daughter ions of m/z 241 and 140. The m/z 634 parent ion produced daughter ions of m/z 241, 213, 196, and 140. The m/z 213 and 241 daughter ions represent C13:0 and C15:0 fatty acids, respectively. The m/z 140 ion represents the phosphoethanolamine head group. See Results for the proposed structure of the m/z 196 ion.

 
P. gingivalis phosphatidylethanolamine lipids were treated with sodium methoxide, and the fatty acid methyl esters were analyzed by GC-MS (Fig. 3 ). Four fatty acid methyl esters were identified. A synthetic standard of isoC15:0 methyl ester demonstrated the same retention time and identical mass spectrum as the dominant fatty acid methyl ester recovered from P. gingivalis phosphatidylethanolamines. Therefore, isoC15:0 (retention time = 8.47 min; 79.02% of the total major fatty acid ion abundance) is the dominant fatty acid methyl ester recovered after transesterification of P. gingivalis phosphatidylethanolamines. Based on the retention times and mass spectra of straight-chain and isobranched synthetic standards, P. gingivalis phosphatidylethanolamines were also shown to contain ester-linked isoC13:0 (retention time = 6.04 min; 12.01%) and lower amounts of C14:0 (retention time = 7.45 min; 0.52%) and C16:0 (retention time = 9.60 min; 8.44%).


Figure 3
View larger version (23K):
[in this window]
[in a new window]
  		Fig. 3. GC-MS analysis of fatty acid methyl esters recovered from phosphatidylethanolamine lipids after hydrolysis with sodium methoxide. Phosphatidylethanolamine lipids were treated with fresh 0.5 N sodium methoxide in anhydrous methanol, and the fatty acid methyl esters were recovered in hexane. The methyl ester fatty acids were then analyzed by GC-MS, as described in Results. The mass spectrum of isobranched (iso)C13:0 is depicted in the middle, and isoC15:0 is depicted at bottom. The abundances of the dominant fatty acid methyl esters are described in Results.

 
P. gingivalis phosphatidylethanolamine lipids were hydrolyzed with phospholipase C according to the method of Kuksis et al. (11). Figure 4 shows the trimethylsilyl derivatives of the major lipid products recovered after phospholipase C hydrolysis. Dimyristoyl phosphatidylethanolamine lipid standard was treated with phospholipase C, and the mass spectrum of the hydrolysis products verified the diacylglycerol structure of P. gingivalis phosphatidylethanolamine lipids. The mass spectrum of the lipid product emerging at 8.95 min (Fig. 4, bottom frame; 45.12% of diglyceride ion abundance) is consistent with a 1,2-diacylglycerol rather than a 1,3-diacylglycerol-substituted structure, as reported by others (13, 14). The lipid product emerging at 7.698 min (39.09% abundance) produced a mass spectrum consistent with diacylglycerol that is substituted with both isoC13:0 and isoC15:0 rather than substituted with only isoC15:0 (lipid product emerging at 8.955 min; 45.12% ion abundance). Odd-chain fatty acids were shown to be isobranched in the phosphatidylethanolamine fraction of P. gingivalis lipids (see above). Based on the partial mass spectra of the other three minor diglycerides recovered, the lipid product emerging at 9.56 min (2.95% ion abundance) contains isoC15:0 and C16:0, the lipid product emerging at 8.43 min (9.71% ion abundance) contains C14:0 and C16:0, and the lipid product emerging at 7.27 min (3.13% ion abundance) contains C14:0. Positive ion chemical ionization GC-MS using methane as the reagent gas produced M+1 m/z proton adduct ions, confirming the masses of the major diacylglycerols as 612 and 584 amu (data not shown). Although the proposed lipid structures place the isoC13:0 on the terminal glycerol carbon, the possibility that the central glycerol carbon is substituted with isoC13:0 cannot be excluded.


Figure 4
Figure 4
View larger version (28K):
[in this window]
[in a new window]
  		Fig. 4. GC-MS analysis of diacylglycerols after treatment of phosphatidylethanolamine lipids with phospholipase C. Approximately 1 mg of phosphatidylethanolamine lipids was treated with phospholipase C, as described in Materials and Methods. Dimyristoyl phosphatidylethanolamine lipid standard (Avanti Polar Lipids, Inc., Alabaster, AL) treated with phospholipase C verified that the diacylglycerols of P. gingivalis phosphatidylethanolamine lipids represent 1,2-diisoC15:0 glycerol (lipid emerging at 8.955 min) or 1-isoC13:0,2-isoC15:0 glycerol (lipid emerging at 7.698 min) (13, 14). The mass spectrum of the major lipid product emerging at 8.95 min (bottom spectrum; 45.12% of diglyceride ion abundance) is consistent with a 1,2-diacylglycerol rather than a 1,3-diacylglycerol-substituted structure, as reported by others (13, 14). See Results for a description of the fatty acid substitutions within the observed diglyceride products.

 
The GC-MS results together with the electrospray-MS results support the structural reconciliation proposed in Fig. 1A. Therefore, the major phosphatidylethanolamine lipids of P. gingivalis are substituted only with isoC15:0 or with isoC15:0 and isoC13:0. Low amounts of phosphatidylethanolamine lipids containing C16:0 and C14:0 are also present.

P. gingivalis phosphatidylethanolamine lipids were tested for activity in promoting IL-1ß- or IL-1{alpha}-mediated prostaglandin secretion from gingival fibroblasts, as shown in Fig. 5 . Included in this trial was a dimyristoyl phosphatidylethanolamine synthetic standard used at the same concentration (10 µg/35 mm culture well) as the phosphatidylethanolamine HPLC fraction. The P. gingivalis phosphatidylethanolamine lipids significantly potentiated IL-1ß- and IL-1{alpha}-mediated PGE2 secretion from gingival fibroblasts, whereas the dimyristoyl phosphatidylethanolamine standard did not stimulate PGE2 release either alone or together with IL-1ß or IL-1{alpha}. The levels of PGE2 shown in Fig. 5 are substantially higher than those shown in Fig. 6 . Fibroblasts from a healthy gingival tissue specimen were used to generate Fig. 5, whereas cells from a diseased gingival tissue specimen were used to generate Fig. 6. Additional work has shown that PGE2 secretion from gingival fibroblasts varies depending on the donor of the gingival tissue, the disease status of the tissue specimen, and the number of cell passages in culture, but the significant trends shown in Figs. 5 and 6 were observed in at least three replicate experiments.


Figure 5
View larger version (11K):
[in this window]
[in a new window]
  		Fig. 5. Effects of P. gingivalis phosphatidylethanolamine lipids on interleukin-1 (IL-1)-mediated prostaglandin secretion from gingival fibroblasts. P. gingivalis phosphatidylethanolamine lipids (10 µg in 20 µl of 100% ethanol) or dimyristoyl phosphatidylethanolamine lipid standard (Avanti Polar Lipids, Inc.) were dispersed into 35 mm plastic culture dishes and air-dried, as described previously (1, 9). Gingival fibroblasts were grown, harvested, and treated with lipids as described (1, 9). Approximately 2 x 106 cells were deposited into each culture well suspended in Minimum Essential Medium supplemented with 10% fetal bovine serum and 100 U/ml penicillin G, 100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B. After a 2 h exposure to bacterial lipids, the culture medium was supplemented with either control medium (30 µl) or medium containing recombinant human IL-1ß or IL-1{alpha} (1 mg/ml, 30 µl; Immunex). The cultures were then incubated for an additional 24 h at 37°C in a humidified 5% CO2 incubator, after which the medium samples were harvested and frozen. Prostaglandin F2{alpha} (PGF2{alpha}), 6-keto PGF1{alpha}, and PGE2 were quantified in medium samples using stable isotope dilution GC-MS analysis, as described previously (1, 9). Each histogram bar depicts the mean ± SD for two trials. P. gingivalis phosphatidylethanolamine (P. ging PE) lipids or phosphatidylethanolamine lipid standard alone (PE std) did not significantly stimulate prostaglandin secretion from gingival fibroblasts compared with the control cells treated with ethanol vehicle alone. Significantly greater PGE2 release was observed from fibroblasts treated with P. gingivalis phosphatidylethanolamine lipids (10 µg) supplemented with either IL-1ß or IL-1{alpha} compared with fibroblasts treated with IL-1ß or IL-1{alpha} alone or treated with dimyristoyl phosphatidylethanolamine plus IL-1ß or IL-1{alpha} (# P < 0.001 by one-factor ANOVA between treatment categories; significantly different at 99% confidence interval by Fisher PLSD). These results were replicated in two additional experiments. Secretion of the other major prostaglandins was not significantly different when comparing the treatment categories.

 

Figure 6
View larger version (17K):
[in this window]
[in a new window]
  		Fig. 6. Biofunctional relevance of the phosphoethanolamine moiety of P. gingivalis phosphatidylethanolamines on the production of prostaglandins by gingival fibroblasts. A sample of P. gingivalis phosphatidylethanolamines was treated with phospholipase C, as described for Figure 4. P. gingivalis phosphatidylethanolamine lipids or their diacylglycerol products (10 µg in 20 µl of 100% ethanol) were dispersed into 35 mm plastic culture wells. Dimyristoyl phosphatidylethanolamine lipid standard (Avanti Polar Lipids, Inc.) was used as the control lipid preparation. Fibroblasts were grown from a fresh gingival tissue explant using the method described for Figure 5. After a 2 h exposure to bacterial lipids, the culture medium was supplemented with either control medium (30 µl) or medium containing recombinant human IL-1ß or IL-1{alpha} (1 mg/ml, 30 µl; Immunex). The cultures were then incubated for an additional 24 h at 37°C in a humidified 5% CO2 incubator, after which the medium samples were harvested and frozen. PGF2{alpha}, 6-keto PGF1{alpha}, and PGE2 were quantified as described for Figure 5. Results are depicted as means ± SD for two trials. P. gingivalis phosphatidylethanolamine lipids (P. ging PE) or PE lipid standard alone (PE std) did not significantly stimulate prostaglandin secretion from gingival fibroblasts compared with vehicle control cells. Fibroblasts treated with IL-1ß or IL-1{alpha} alone or dimyristoyl phosphatidylethanolamine standard plus IL-1ß or IL-1{alpha} released significantly less PGE2 than cells treated with P. gingivalis phosphatidylethanolamine lipids plus IL-1ß or IL-1{alpha} (# P < 0.001 by one-factor ANOVA between treatment categories; significantly different at 99.9% confidence interval by Fisher PLSD). The diacylglycerol lipid preparation of P. gingivalis phosphatidylethanolamine lipids (10 µg) together with IL-1ß or IL-1{alpha} did not potentiate PGE2 secretion over that observed with IL-1ß or IL-1{alpha} alone.

 
Note that the primary effect of P. gingivalis phosphatidylethanolamines on prostaglandin secretion is limited to PGE2, as described previously for phosphoglycerol dihydroceramides (1). Treatment of P. gingivalis phosphatidylethanolamine lipids with phospholipase C produced the expected diacylglycerols, as demonstrated in Fig. 4. Gingival fibroblasts treated with the diacylglycerols of P. gingivalis followed by IL-1ß or IL-1{alpha} did not secrete increased levels of PGE2 compared with IL-1 alone (Fig. 6), indicating the involvement of the phosphoethanolamine moiety in the biofunctional activity of the phosphatidylethanolamine lipids of P. gingivalis. Phosphatidylethanolamine lipids of P. gingivalis alone did not significantly stimulate prostaglandin secretion from gingival fibroblasts but did alter the morphology of gingival fibroblasts in culture, as shown in Fig. 7 . P. gingivalis phosphatidylethanolamine lipids caused significant morphological changes in fibroblasts and cell detachment regardless of treatment with IL-1ß or IL-1{alpha} (data not shown). Therefore, the phosphatidylethanolamine lipids of P. gingivalis markedly potentiate IL-1ß- and IL-1{alpha}-mediated PGE2 secretion from gingival fibroblasts but also induce substantial changes in fibroblast shape and adherence in culture.


Figure 7
Figure 7
Figure 7
View larger version (150K):
[in this window]
[in a new window]
  		Fig. 7. Morphological appearance of gingival fibroblasts after treatment with lipid preparations. The cell cultures described for Figure 5 were photographed at the end of the culture period (26 h). A: Control cells exposed to culture wells previously coated with ethanol vehicle alone. B: Cells exposed to culture wells coated with dimyristoyl phosphatidylethanolamine lipid standard (10 µg; Avanti Polar Lipids, Inc.). C: Cells exposed to phosphatidylethanolamine lipids from P. gingivalis (10 µg). Supplementing cultures with IL-1ß or IL-1{alpha} treatment did not affect the appearance of fibroblasts compared with cells exposed to dimyristoyl phosphatidylethanolamine lipid standard or P. gingivalis phosphatidylethanolamine lipids alone (data not shown).

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
Although previous reports demonstrated phosphatidylethanolamines in lipid extracts of P. gingivalis (15) and a related organism, Bacteroides melaninogenicus (16), this study identifies the novel structural characteristics of P. gingivalis phosphatidylethanolamines as well as the role of these novel structural constituents in promoting biological activity. Based on the evidence provided here, the isobranched fatty acids together with the phospholipid head group dictate the biological activity of the phosphatidylethanolamine lipids of P. gingivalis. Substitution of straight-chain fatty acids for isobranched fatty acids or removal of the phosphoethanolamine head group virtually eliminated the biological activity observed with phosphatidylethanolamine lipids of P. gingivalis. The isobranched fatty acids, therefore, confer biological activity through the branched aliphatic chains. Although the phosphorylated head group is essential for the biological activity, the phosphoethanolamine group is not structurally unique.

Complex lipids of P. gingivalis, including phosphoethanolamines, are believed to be constituents of cell walls and membrane vesicles that are shed from this organism (17–19). P. gingivalis is unusual among periodontal organisms in its capacity to shed membrane vesicles or blebs. Complex lipids of P. gingivalis are also recovered at periodontal disease sites, as demonstrated in lipid extracts of teeth covered with subgingival calculus as well as gingival tissues afflicted with chronic inflammatory periodontal disease (3). Several plausible mechanisms could account for periodontal tissue contamination with lipids of P. gingivalis, including direct adhesion between bacteria and host epithelial cells in the gingival sulcus surrounding each tooth (20–23), direct contact between host tissues and lipid-contaminated diseased teeth, or invasion of periodontal tissues by P. gingivalis (24–31). Because complex lipids of P. gingivalis are most prevalent on periodontally diseased tooth roots (3, 9), this study exposed gingival fibroblasts to lipid films that recreate the approximate lipid levels observed on calculus-contaminated tooth roots. A previous report indirectly estimated P. gingivalis lipid levels on calculus-contaminated tooth roots by quantifying 3-OH isoC17:0 on root sections of known surface area (9). Replicate HPLC fractionations of total lipid extracts also demonstrated that at least 15% of P. gingivalis lipids represent phosphatidylethanolamine lipids. Based on these findings, we estimated that calculus-contaminated tooth root surfaces retain P. gingivalis phosphatidylethanolamine lipids at levels that exceed a dose of 10 µg of phosphatidylethanolamine lipid per 35 mm culture dish. This was the dose of P. gingivalis phosphatidylethanolamine lipids selected for the experiments reported here. However, another experiment demonstrated that exposure of fibroblasts to 5 µg of P. gingivalis phosphatidylethanolamine lipids promoted IL-1-mediated PGE2 secretion (increased PGE2 release by >40% over IL-1 controls) to a lesser extent than the 10 µg dose.

Other work has shown that exposure of cells to lower levels of P. gingivalis phosphatidylethanolamine lipids will promote biological responses. However, it is not established what levels of P. gingivalis phosphatidylethanolamines will mimic target cell lipid exposures typical of periodontal disease tissue levels or systemic bacteremias. Future studies will quantify periodontal tissue and systemic exposures to these bacterial lipids, and will use these levels to examine the biological effects of these lipid preparations in promoting autoimmune, atherosclerosis, and degenerative systemic diseases at the relevant exposure levels.

The capacity of P. gingivalis phosphatidylethanolamines to promote PGE2 secretion and alter fibroblast morphology is very similar to that reported for phosphoglycerol dihydroceramides of P. gingivalis (1). P. gingivalis produces free, phosphoethanolamine, and phosphoglycerol dihydroceramide classes all with core structures consisting of 3-OH isoC17:0 in amide linkage to isoC17:0, C18:0, and isoC19:0 long-chain bases. Of these dihydroceramide classes, only the phosphoglycerol dihydroceramide class markedly stimulates PGE2 secretion and alters fibroblast morphology. Only the phosphoglycerol dihydroceramides contain isoC15:0 linked to the ß-hydroxyl of 3-OH isoC17:0, and the proximity of branched aliphatic chains within this lipid class likely contributes to the biological activity of these phosphoglycerol dihydroceramides. Further support for the role of the branched aliphatic chains in promoting biological activity comes from recent work demonstrating that removal of isoC15:0 from the phosphoglycerol dihydroceramides substantially reduces the capacity of this lipid class to promote IL-1-mediated prostaglandin secretion (data not shown). Additional preliminary work indicates that both the phosphatidylethanolamine and phosphoglycerol dihydroceramide lipid classes activate the phosphorylation of mitogen-activated protein kinase family proteins in RAW264.7 cells, including p38 mitogen-activated protein kinase, extracellular signal regulated protein kinases (ERK1/2), and C-jun kinase (JNK). Therefore, the isobranched aliphatic chains of phosphoglycerol dihydroceramides and phosphatidylethanolamines of P. gingivalis appear to be critical to the biofunctional activity of these lipids. However, the mechanisms by which host cells recognize isobranched fatty acids of P. gingivalis phosphatidylethanolamines and promote PGE2 and morphological changes in fibroblast cells remain to be characterized.

In summary, the results of this study indicate that the close proximity of isobranched fatty acid aliphatic chains with the phosphorylated head group accounts for the biological responses observed in cultured gingival fibroblasts after exposure to phosphatidylethanolamines of P. gingivalis. Activation of host cells likely involves a microbial pattern receptor that specifically recognizes the combination of isobranched aliphatic chains together with the phosphorylated head group in lipids from Porphyromonas species. Therefore, these findings, together with previously reported evidence demonstrating biological effects of phosphorylated dihydroceramides, suggest a new paradigm for microbial lipids to act as virulence factors in promoting inflammatory diseases, including but not limited to chronic inflammatory periodontal diseases.

Manuscript received December 16, 2005 and in revised form January 24, 2006.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
  1. Nichols, F. C., B. Riep, J. Mun, M. D. Morton, M. T. Bojarski, F. E. Dewhirst, and M. B. Smith. 2004. Structures and biological activity of phosphorylated dihydroceramides of Porphyromonas gingivalis. J. Lipid Res. 45: 2317–2330.[Abstract/Free Full Text]

  2. Nichols, F. C. 1998. Novel ceramides recovered from Porphyromonas gingivalis: relationship to adult periodontitis. J. Lipid Res. 39: 2360–2372.[Abstract/Free Full Text]

  3. Nichols, F. C., and K. Rojanasomsith. 2006. Porphyromonas gingivalis lipids and diseased dental tissues. Oral Microbiol. Immunol. In press.

  4. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911–917.

  5. Garbus, J., H. F. DeLuca, M. E. Loomas, and F. M. Strong. 1968. Rapid incorporation of phosphate into mitochondrial lipids. J. Biol. Chem. 238: 59–63.

  6. Hax, W. M. A., and W. S. M. Geurts Van Kessel. 1977. High-performance liquid chromatographic separation and photometric detection of phospholipids. J. Chromatogr. 142: 735–741.[CrossRef][Medline]

  7. Richards, D., and R. B. Rutherford. 1988. The effects of interleukin-1 on collagenolytic activity and prostaglandin E secretion by human periodontal ligament and gingival fibroblasts. Arch. Oral Biol. 33: 237–243.[CrossRef][Medline]

  8. Luderer, J. R., D. L. Riley, and L. M. Demers. 1983. Rapid extraction of arachidonic acid metabolites utilizing octadecyl reversed-phase columns. J. Chromatogr. 273: 402–409.[Medline]

  9. Nichols, F. C., H. Levinbook, M. Shnaydman, and J. Goldschmidt. 2001. Prostaglandin E2 secretion from gingival fibroblasts treated with interleukin-1beta: effects of lipid extracts from Porphyromonas gingivalis or calculus. J. Periodontal Res. 36: 142–152.[CrossRef][Medline]

  10. Waddell, K. A., I. A. Blair, and J. Wellby. 1983. Combined capillary column gas chromatography negative ion chemical ionization mass spectrometry of prostanoids. Biomed. Mass Spectrom. 10: 83–88.

  11. Kuksis, A., J. J. Myher, K. Geher, N. A. Shaikh, W. C. Breckenridge, G. J. Jones, and J. A. Little. 1980. Comparative determination of plasma phospholipids by automated gas-liquid chromatographic and manual colorimetric phosphorus methods. J. Chromatogr. 182: 1–26.[CrossRef][Medline]

  12. Christie, W. 2003. Lipid Analysis: Isolation, Separation, Identification and Structural Analysis of Lipids. The Oily Press, Bridgwater, England.

  13. Horning, M., G. Casparrini, and E. Horning. 1969. The use of gas phase analytical methods for the analysis of phospholipids. J. Chromatogr. Sci. 7: 267–275.

  14. Viswanathan, C. V. 1974. Coupled gas chromatography-mass spectrometry in the separation and characterization of polar lipids. J. Chromatogr. 98: 105–128.[CrossRef][Medline]

  15. Tavana, A. M., M. Korachi, V. Boote, P. S. Hull, D. N. Love, and D. B. Drucker. 2000. Phospholipid analogues of Porphyromonas gingivalis. J. Appl. Microbiol. 88: 791–799.[CrossRef][Medline]

  16. Rizza, V., A. N. Tucker, and D. C. White. 1970. Lipids of Bacteroides melaninogenicus. J. Bacteriol. 101: 84–91.[Abstract/Free Full Text]

  17. Mayrand, D., and D. Grenier. 1989. Biological activities of outer membrane vesicles. Can. J. Microbiol. 35: 607–613.[Medline]

  18. Grenier, D., and M. Belanger. 1991. Protective effect of Porphyromonas gingivalis outer membrane vesicles against bactericidal activity of human serum. Infect. Immun. 59: 3004–3008.[Abstract/Free Full Text]

  19. Duchesne, P., D. Grenier, and D. Mayrand. 1995. Demonstration of adherence properties of Porphyromonas gingivalis outer membrane vesicles using a new microassay. Oral Microbiol. Immunol. 10: 76–80.[Medline]

  20. Du, L., P. Pellen-Mussi, F. Chandad, C. Mouton, and M. Bonnaure-Mallet. 1992. Further evidence for a possible role of trypsin-like activity in the adherence of Porphyromonas gingivalis. Infect. Immun. 38: 1189–1192.

  21. Du, L., P. Pellen-Mussi, F. Chandad, C. Mouton, and M. Bonnaure-Mallet. 1997. Fimbriae and the hemagglutinating adhesin HA-Ag2 mediate adhesion of Porphyromonas gingivalis to epithelial cells. Infect. Immun. 65: 3875–3881.[Abstract]

  22. Chen, T., K. Nakayama, L. Belliveau, and M. J. Duncan. 2001. Porphyromonas gingivalis gingipains and adhesion to epithelial cells. Infect. Immun. 69: 3048–3056.[Abstract/Free Full Text]

  23. Chen, T., K. Nakayama, L. Belliveau, and M. J. Duncan. 2001. Porphyromonas gingivalis gingipains and adhesion to epithelial cells: Role of the amino-terminal region of Porphyromonas gingivalis fimbriae in adherence to epithelial cells. Infect. Immun. 69: 3048–3056.[Abstract/Free Full Text]

  24. Saglie, F. R., C. T. Smith, M. G. Newman, F. A. Carranza, Jr., J. H. Pertuiset, L. Cheng, E. Auil, and R. J. Nisengard. 1986. The presence of bacteria in the oral epithelium in periodontal disease. II. Immunohistochemical identification of bacteria. J. Periodontol. 57: 492–500.[Medline]

  25. Saglie, F. R., J. H. Pertuiset, C. T. Smith, M. G. Nestor, F. A. Carranza, Jr., M. G. Newman, M. T. Rezende, and R. Nisengard. 1987. The presence of bacteria in the oral epithelium in periodontal disease. III. Correlation with Langerhans cells. J. Periodontol. 58: 417–422.[Medline]

  26. Lamont, R. J., D. Oda, R. E. Persson, and G. R. Persson. 1992. Interaction of Porphyromonas gingivalis with gingival epithelial cells maintained in culture. Oral Microbiol. Immunol. 7: 364–367.[Medline]

  27. Lamont, R. J., A. Chan, C. M. Belton, K. T. Izutsu, D. Vasel, and A. Weinberg. 1995. Porphyromonas gingivalis invasion of gingival epithelial cells. Infect. Immun. 63: 3878–3885.[Abstract]

  28. Sandros, J., P. N. Papapanou, U. Nannmark, and G. Dahlen. 1994. Porphyromonas gingivalis invades human pocket epithelium in vitro. J. Periodontal Res. 29: 62–69.[CrossRef][Medline]

  29. Sandros, J., P. Papapanou, and G. Dahlen. 1993. Porphyromonas gingivalis invades oral epithelial cells in vitro. J. Periodontal Res. 28: 219–226.[CrossRef][Medline]

  30. Weinberg, A., C. M. Belton, Y. Park, and R. J. Lamont. 1997. Role of fimbriae in Porphyromonas gingivalis invasion of gingival epithelial cells. Infect. Immun. 65: 313–316.[Abstract]

  31. Sojar, H. T., A. Sharma, and R. J. Genco. 2002. Porphyromonas gingivalis fimbriae bind to cytokeratin of epithelial cells. Infect. Immun. 70: 96–101.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Dent. Res.Home page
J. Zahlten, B. Riep, F.C. Nichols, C. Walter, B. Schmeck, J.-P. Bernimoulin, and S. Hippenstiel
Porphyromonas gingivalis Dihydroceramides Induce Apoptosis in Endothelial Cells
J. Dent. Res., July 1, 2007; 86(7): 635 - 640.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M500542-JLR200v1
47/4/844    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nichols, F. C.
Right arrow Articles by Smith, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nichols, F. C.
Right arrow Articles by Smith, M. B.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today